Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$BIEL How to Keep Chronic Pain Away with ActiPatch - By ACTIPATCH
$BIEL ActiPatch on TV in South Africa
Chronic pain relief - By ActiPatch
$BIEL* Anyone using pulsed shortwave therapy for post-procedure or post-op or chronic pain?*
This FDA approved device is called Recovery Rx and is non-invasive...can't feel it....attaches with tape to the skin or even over thin clothing.
I write about cool and cutting edge stuff that helps my patients or me.
In this case...I was dealing with chronic posterior shoulder trigger point pain...bad enough to limit my overhead motion. I tried a bunch of things....this $50 wearable and disposable device worked.
I did a huge randomized totally blinded and totally unbiased trial with just me (N=1) as patient, clinician, and observer. I have gone with and without the device over a week now and no question my pain is gone with it. Have a look...may be worth investigating or trialing. This is not medical advice.... I am not a consultant and gain nothing for reporting this news! Plus I hear their head honcho for sales played ball for the Rangers so that is the rest of the story!
BioElectronics Corporation Keith Nalepka
$BIEL Partnered with Modern Development Medical Co.
Modern Development Medical Co.
MD is the fastests growing medical company in Kuwait
Now distributing Recovery Rx® and ActiPatch® to medical professionals
http://mdmedical.co/bio-electronics.html
$BIEL Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for analgesia and opioid sparing following outpatient surgery: A proof-of-concept case series
Case report: Following moderately painful ambulatory umbilical (n = 3) and inguinal (n = 2) hernia repair as well as bilateral breast surgery (n = 2), patients had taped over their surgical incision(s) 1 or 2 noninvasive, wearable, disposable, pulsed shortwave therapy devices (RecoveryRx, BioElectronics Corporation, Frederick, Maryland) which functioned continuously for 30 days. Average resting pain scores measured on the 0-10 numeric rating scale were a median of 0 during the entire treatment period. Six patients avoided opioid use entirely, while the remaining individual required only 5 mg of oxycodone during the first postoperative day.
https://pubmed.ncbi.nlm.nih.gov/36463434/
$BIEL Recovery Rx is listed on the Federal Supply Schedule Price List page 2
https://www.gsaadvantage.gov/ref_text/36F79720D0009/36F79720D0009_online.htm
$BIEL ELECTROMAGNETIC PAIN RELIEF/BLOCKING: FEASIBILITY ASSESSMENT
https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf
ELECTROMAGNETIC PAIN RELIEF/BLOCKING: FEASIBILITY ASSESSMENT
page 15
The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range)
transmitter operated adjacent to biological tissue at maximum
output (saturation) to modulate peripheral nerve activity.
ActiPatch is a very small wearable PSWT device that is FDA
approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97%
efficacy in reducing pain (85% over a 6-month period) [Staelin
2019]. The device can be secured to the body by physio tape and
the area causing pain is bounded by the device’s ring. The device
can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch
2020].
$BIEL The NO PAIN ACT is now LAW
NO PAIN Act
In March 2021, Senators Portman (R-OH), Shelley Moore Capito (R-WV), Jeanne Shaheen (D-NH), and Joe Manchin (D-WV) introduced the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. The legislation aims to help address barriers to non-opioid pain management for those enrolled in Medicare, which will help stem the opioid epidemic across the nation.
Possible new anti-fungal drug?
Brilacidin now in Ophthalmology news magazine.
https://www.ophthalmologytimes.com/view/innovation-pharmaceuticals-details-in-vivo-antifungal-data-showing-brilacidin-s-potential-for-treating-fungal-keratitis
$BIEL CASE REPORT
Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for analgesia and opioid sparing following outpatient surgery: A proof-of-concept case series
https://onlinelibrary.wiley.com/doi/abs/10.1111/papr.13188
$BIEL Noninvasive, Wearable, Pulsed Shortwave (Radiofrequency) Therapy for
Analgesia following Knee and Hip Arthroplasty: A Case Series
https://t.co/SH71DZZOQi
$BIEL The RecoveryRx® is the Gold Star for BioElectronics Corporation
The RecoveryRx® is sweeping through the global medical industry and getting noticed fast.
$BIEL MEDICA Trade Fair 2022 in Düsseldorf Germany
Maryland Department of Commerce
BioElectronics Corporation ActiPatch
BioElectronics Corporation is a leader in non-invasive electroceuticals and the manufacturer of industry leading disposable, drug-free, pain therapy devices for the over-the-counter treatment of back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative pain and wound care.
$BIEL KT Recovery+ Wave™ at the ExCel London
ExCeL London is an exhibition and international convention center in the Custom House area of Newham, East London. ExCeL London is dubbed the 'most connected event venue'. KT Tape was there with the KT Recovery+ Wave™.
$BIEL sells in all these countries!
Countries now using $BIEL products ActiPatch/Recovery Rx/KT Recovery Wave/ Healfast Pet Patch Loop
$BIEL The Exciting Story of BioElectronics Corp.
https://microcapdaily.com/the-exciting-story-of-bioelectronics-corp-otcpink-biel/
https://microcapdaily.com/bioelectronics-corp-otcpink-biel-getting-noticed-fast-as-biotech-inks-new-orders-initiates-new-studies-and-its-recoveryrx-actipatch-gain-traction/
https://microcapdaily.com/bioelectronics-corp-otcpink-biel-major-reversal-as-pain-management-pioneer-reports-record-revenues-readies-launch-of-its-kt-recovery-wavetm-in-the-uk/
https://www.bielcorp.com/
$QGEN - finally getting the love it deserves !
Look for a test of 52 week high
I highly recommend you check out Antibe Therapeutics $ATBPF for an investment and trading opportunity. To put it simply, they have created a safer version of NSAIDS (Naproxen, Asprin, etc). NSAIDS are notorious for causing ulcers. To say this is a large market is an understatement. Their final Phase2b results, which is the most crucial for bios, are out in a few weeks.
Not only is their drug much safer, it is also way stronger. A double victory. Their founder, John Wallace, is one of the top gastroenterologist in the world and is highly respected in his field.
https://en.wikipedia.org/wiki/John_L._Wallace
Reasons I like the stock/company:
For the target market it is extremely undervalued.
Last Phase2B results were incredible.
Very good team, their Chairman of board is the Vice Chairman of Mastercard!
Because it is Canadian it is very under the radar in the States (undervalued)
Uplisting to Nasdaq later this year.
Fully funded for the rest of trial and rest of year
Already have licensing deals
They hired Dr. Rami Batal, from Canopy fame," in the new role of Senior VP, Commercial Strategy. The creation of this position represents a further step in the Company’s partnering efforts for its lead drug, ATB-346, and for its overall drug platform."
Stock has been beaten down from all time highs due to this Corona nightmare, providing a great entry point.
Multiple analyst give this a price target of $1.30 and higher (with good results)
Negatives:
Low volume on the US side
That's about it LOL
Like any bio in testing phases if they fail it will tank
Based on 2 years of hardcore research, I give this about a 95% of having great results and a huge partnership and/or buyout later this year.
Disclosure: I am long $ATBPF
Anyone invested in this?
Looks incredible, I'll be following this
First GMP-certified cannapill to market ? It`s possible - this month it will reach Australia, coming in from Canada. Then they have to be approved by the FDA-of-Australia. Check out the biotech GMP-certified plant.
QBL-Strategy; establish a strong "first mover advantage" in Australia, then aim for the gigantic Asian market next door.
Hot; turned down a take-over-bid last week.
Take a look at Mrs Feldman track-record; built up a fortune selling tiny mining business to Kinross, DeBeers (worlds largest diamond comp.) and others. Her brother (on the board) diamond-magnate.
Now; Revenue start coming from there hemp products brand. Australias largest with "monopoly" on certain hemp products; they have the only state-of-the-art machines and supply there competion with the product = control of the source, control of the market.
https://docs.wixstatic.com/ugd/1943b6_9a2f1cc...545fad.pdf
(link works on the board and website)
(see board and QBL website)
Licensed medical cannabis farm in Oregon and California research garden. Yes, with these resources in the back, Queensland Bauxite has recruited a well-known expert to join the team. It`s John Easterling, married to Olivia Newton-John and shares her passion in supporting the growth of the Olivia Newton-John Cancer Wellness and Research Centre in Melbourne.
It was in Sydney the 18 of january the statement was announced;
"I am delighted and proud on behalf of the Board of Queensland Bauxite Limited to inform our shareholders that Mr John Easterling has agreed to join the board of our Cannabis subsidiary Medical Cannabis Limited."
(Canada)
John comes with a wealth of experience in developing therapeutical products from plants, which includes many years of experience in medical Cannabis cultivation and products. John is a big advocate for legislation reform in Australia to allow wider access to medical cannabis. He has met on numerous occasions with influential government officials on both sides of parliament, both the Prime Minister and members of the Coalition government.
You don`t want to miss this one; check board and you understand why.
"The Board believes that the addition of Mr Easterling and his experience, knowledge and contacts to the team of MCL, will add enormous value and assistance to MCL, to ensure that it continues to be the leading medical Cannabis and hemp company in Australia as the industry continues to open up to the massive local and global market opportunities."
Anyone looking at AXSM (Axsome)? 2 Phase 3 results this month (probs next week) and 1 phase 3 first half next year. Great pipeline too.
Check their company presentation (3rd link):
http://phx.corporate-ir.net/phoenix.zhtml?c=254022&p=irol-presentations
Average pricetarget $20.
ENDV Electroceuticals developers with patents
President buying heavily
latest news: results in next few weeks
https://www.otcmarkets.com/stock/ENDV/news/Endonovo-Therapeutics-Provides-Update-on-Pre-Clinical-Studies?id=170850&b=y